| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |